Cargando…

Prostate Cancer Review: Genetics, Diagnosis, Treatment Options, and Alternative Approaches

SIMPLE SUMMARY: Prostate cancer affects men of all racial and ethnic groups and leads to higher rates of mortality in those belonging to a lower socioeconomic status due to late detection of the disease. There is growing evidence that suggests the contribution of an individual’s genetic profile to p...

Descripción completa

Detalles Bibliográficos
Autores principales: Sekhoacha, Mamello, Riet, Keamogetswe, Motloung, Paballo, Gumenku, Lemohang, Adegoke, Ayodeji, Mashele, Samson
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9457814/
https://www.ncbi.nlm.nih.gov/pubmed/36080493
http://dx.doi.org/10.3390/molecules27175730
_version_ 1784786148552343552
author Sekhoacha, Mamello
Riet, Keamogetswe
Motloung, Paballo
Gumenku, Lemohang
Adegoke, Ayodeji
Mashele, Samson
author_facet Sekhoacha, Mamello
Riet, Keamogetswe
Motloung, Paballo
Gumenku, Lemohang
Adegoke, Ayodeji
Mashele, Samson
author_sort Sekhoacha, Mamello
collection PubMed
description SIMPLE SUMMARY: Prostate cancer affects men of all racial and ethnic groups and leads to higher rates of mortality in those belonging to a lower socioeconomic status due to late detection of the disease. There is growing evidence that suggests the contribution of an individual’s genetic profile to prostate cancer. Currently used prostate cancer treatments have serious adverse effects; therefore, new research is focusing on alternative treatment options such as the use of genetic biomarkers for targeted gene therapy, nanotechnology for controlled targeted treatment, and further exploring medicinal plants for new anticancer agents. In this review, we describe the recent advances in prostate cancer research. ABSTRACT: Prostate cancer is one of the malignancies that affects men and significantly contributes to increased mortality rates in men globally. Patients affected with prostate cancer present with either a localized or advanced disease. In this review, we aim to provide a holistic overview of prostate cancer, including the diagnosis of the disease, mutations leading to the onset and progression of the disease, and treatment options. Prostate cancer diagnoses include a digital rectal examination, prostate-specific antigen analysis, and prostate biopsies. Mutations in certain genes are linked to the onset, progression, and metastasis of the cancer. Treatment for localized prostate cancer encompasses active surveillance, ablative radiotherapy, and radical prostatectomy. Men who relapse or present metastatic prostate cancer receive androgen deprivation therapy (ADT), salvage radiotherapy, and chemotherapy. Currently, available treatment options are more effective when used as combination therapy; however, despite available treatment options, prostate cancer remains to be incurable. There has been ongoing research on finding and identifying other treatment approaches such as the use of traditional medicine, the application of nanotechnologies, and gene therapy to combat prostate cancer, drug resistance, as well as to reduce the adverse effects that come with current treatment options. In this article, we summarize the genes involved in prostate cancer, available treatment options, and current research on alternative treatment options.
format Online
Article
Text
id pubmed-9457814
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-94578142022-09-09 Prostate Cancer Review: Genetics, Diagnosis, Treatment Options, and Alternative Approaches Sekhoacha, Mamello Riet, Keamogetswe Motloung, Paballo Gumenku, Lemohang Adegoke, Ayodeji Mashele, Samson Molecules Review SIMPLE SUMMARY: Prostate cancer affects men of all racial and ethnic groups and leads to higher rates of mortality in those belonging to a lower socioeconomic status due to late detection of the disease. There is growing evidence that suggests the contribution of an individual’s genetic profile to prostate cancer. Currently used prostate cancer treatments have serious adverse effects; therefore, new research is focusing on alternative treatment options such as the use of genetic biomarkers for targeted gene therapy, nanotechnology for controlled targeted treatment, and further exploring medicinal plants for new anticancer agents. In this review, we describe the recent advances in prostate cancer research. ABSTRACT: Prostate cancer is one of the malignancies that affects men and significantly contributes to increased mortality rates in men globally. Patients affected with prostate cancer present with either a localized or advanced disease. In this review, we aim to provide a holistic overview of prostate cancer, including the diagnosis of the disease, mutations leading to the onset and progression of the disease, and treatment options. Prostate cancer diagnoses include a digital rectal examination, prostate-specific antigen analysis, and prostate biopsies. Mutations in certain genes are linked to the onset, progression, and metastasis of the cancer. Treatment for localized prostate cancer encompasses active surveillance, ablative radiotherapy, and radical prostatectomy. Men who relapse or present metastatic prostate cancer receive androgen deprivation therapy (ADT), salvage radiotherapy, and chemotherapy. Currently, available treatment options are more effective when used as combination therapy; however, despite available treatment options, prostate cancer remains to be incurable. There has been ongoing research on finding and identifying other treatment approaches such as the use of traditional medicine, the application of nanotechnologies, and gene therapy to combat prostate cancer, drug resistance, as well as to reduce the adverse effects that come with current treatment options. In this article, we summarize the genes involved in prostate cancer, available treatment options, and current research on alternative treatment options. MDPI 2022-09-05 /pmc/articles/PMC9457814/ /pubmed/36080493 http://dx.doi.org/10.3390/molecules27175730 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Sekhoacha, Mamello
Riet, Keamogetswe
Motloung, Paballo
Gumenku, Lemohang
Adegoke, Ayodeji
Mashele, Samson
Prostate Cancer Review: Genetics, Diagnosis, Treatment Options, and Alternative Approaches
title Prostate Cancer Review: Genetics, Diagnosis, Treatment Options, and Alternative Approaches
title_full Prostate Cancer Review: Genetics, Diagnosis, Treatment Options, and Alternative Approaches
title_fullStr Prostate Cancer Review: Genetics, Diagnosis, Treatment Options, and Alternative Approaches
title_full_unstemmed Prostate Cancer Review: Genetics, Diagnosis, Treatment Options, and Alternative Approaches
title_short Prostate Cancer Review: Genetics, Diagnosis, Treatment Options, and Alternative Approaches
title_sort prostate cancer review: genetics, diagnosis, treatment options, and alternative approaches
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9457814/
https://www.ncbi.nlm.nih.gov/pubmed/36080493
http://dx.doi.org/10.3390/molecules27175730
work_keys_str_mv AT sekhoachamamello prostatecancerreviewgeneticsdiagnosistreatmentoptionsandalternativeapproaches
AT rietkeamogetswe prostatecancerreviewgeneticsdiagnosistreatmentoptionsandalternativeapproaches
AT motloungpaballo prostatecancerreviewgeneticsdiagnosistreatmentoptionsandalternativeapproaches
AT gumenkulemohang prostatecancerreviewgeneticsdiagnosistreatmentoptionsandalternativeapproaches
AT adegokeayodeji prostatecancerreviewgeneticsdiagnosistreatmentoptionsandalternativeapproaches
AT mashelesamson prostatecancerreviewgeneticsdiagnosistreatmentoptionsandalternativeapproaches